Significant Accounting Policies (Details Narrative)
|
12 Months Ended |
|
|
Apr. 30, 2020
USD ($)
Supplier
shares
|
Apr. 30, 2019
USD ($)
Supplier
$ / shares
shares
|
May 02, 2019
USD ($)
|
| Cash and cash equivalents |
$ 11,742,728
|
$ 3,912,135
|
|
| Deferred sales revenue |
2,700,000
|
2,500,000
|
|
| Share-based compensation expense |
6,904,193
|
3,554,451
|
|
| Sales commission payable |
7,983,536
|
7,402,659
|
|
| Operating lease, right-of-use asset |
800,381
|
|
|
| Operating lease, liability |
820,898
|
|
|
| ASU 2016-02 [Member] |
|
|
|
| Operating lease, right-of-use asset |
|
|
$ 1,400,000
|
| Operating lease, liability |
|
|
$ 1,400,000
|
| Including Estimated Liability [Member] |
|
|
|
| Sales commission expense |
|
1,633,325
|
|
| Estimated Sales Commission Payable [Member] |
|
|
|
| Sales commission payable |
$ 1,290,477
|
$ 1,365,705
|
|
| Common Stock [Member] |
|
|
|
| Number of fully vested warrants issued to purchase common stock | shares |
628,800
|
1,582,600
|
|
| Number of estimated fair value of warrants |
$ 95,445
|
$ 1,365,705
|
|
| Common Stock [Member] | Sales Related Warrants [Member] |
|
|
|
| Number of fully vested warrants issued to purchase common stock | shares |
|
11,000,000
|
|
| Number of estimated fair value of warrants |
|
$ 1,805,287
|
|
| Warrants term |
|
2 years
|
|
| Warrants exercise price | $ / shares |
|
$ 0.25
|
|
| Selling and Marketing Expense [Member] |
|
|
|
| Sales commission expense |
$ 59,000,000
|
$ 41,500,000
|
|
| Sales Revenue, Net [Member] | Coffee and Coffee Related Products [Member] |
|
|
|
| Concentration risk, percentage |
25.00%
|
|
|
| Sales Revenue, Net [Member] | D.O.S.E. Nutraceutical Products [Member] |
|
|
|
| Concentration risk, percentage |
52.00%
|
|
|
| Sales Revenue, Net [Member] | United States [Member] |
|
|
|
| Concentration risk, percentage |
95.00%
|
96.00%
|
|
| Sales Revenue, Net [Member] | No Individual Customer [Member] |
|
|
|
| Concentration risk, percentage |
10.00%
|
|
|
| Sales Revenue, Net [Member] | No Individual Customer [Member] | United States [Member] |
|
|
|
| Concentration risk, percentage |
95.00%
|
96.00%
|
|
| Sales Revenue, Net [Member] | Recurring Customers [Member] |
|
|
|
| Concentration risk, percentage |
47.00%
|
|
|
| Sales Revenue, Net [Member] | New Customer [Member] |
|
|
|
| Concentration risk, percentage |
26.00%
|
|
|
| Sales Revenue, Net [Member] | Independent Distributors [Member] |
|
|
|
| Concentration risk, percentage |
27.00%
|
|
|
| Sales Revenue, Net [Member] | Elevate Product Line [Member] |
|
|
|
| Concentration risk, percentage |
98.00%
|
97.00%
|
|
| Purchases [Member] | One Supplier [Member] |
|
|
|
| Concentration risk, percentage |
98.00%
|
96.00%
|
|
| Number of suppliers | Supplier |
1
|
1
|
|
| Services Offered on Subscription Basis [Member] |
|
|
|
| Deferred sales revenue |
$ 433,386
|
$ 515,087
|
|
| Customers Right of Return [Member] |
|
|
|
| Deferred sales revenue |
263,117
|
194,042
|
|
| Merchant Processors [Member] |
|
|
|
| Cash and cash equivalents |
11,100,000
|
3,500,000
|
|
| Accounts receivable, related parties |
4,200,000
|
4,500,000
|
|
| One Merchant Processors [Member] |
|
|
|
| Accounts receivable, related parties |
$ 4,000,000
|
$ 4,100,000
|
|